moved that Bill C-15, An Act to amend the Controlled Drugs and Substances Act and to make related and consequential amendments to other Acts, be read the second time and referred to a committee.
Mr. Speaker, it is my great pleasure to speak to Bill C-15 today.
Members will recall that, in November 2007, the Minister of Justice introduced Bill C-26, which proposed a number of mandatory minimum penalties to ensure that appropriately high sentences are imposed on those who commit serious drug offences. This bill reintroduces those same provisions.
As we all know, the Prime Minister unveiled Canada's new national anti-drug strategy in October 2007. The national anti-drug strategy provides funding to prevent the consumption of illegal drugs, particularly among young people, to treat addictions and to fight drug-related crime.
This strategy has a two-pronged approach: the first focuses on a tougher response to drug-related crime and the second on victims.
The national anti-drug strategy includes three action plans: preventing the consumption of illegal drugs, treating addictions, and tackling the production and distribution of illegal drugs.
The action plan to fight the production and distribution of illegal drugs contains a number of elements, including sufficiently severe penalties for serious drug-related offences.
That is part of the context in which this bill should be seen. It takes action on one of the government’s major priorities, which is to attack crime, and especially organized crime.
The purpose of this bill is not to provide minimum obligatory penalties for all drug-related offences. The Controlled Drugs and Substances Act is quite complex when it comes to various offences and punishments. The punishment depends on both the kind of crime committed and the substance involved. The most dangerous substances that cause the greatest problems, such as heroin, cocaine, methamphetamine and morphine, are included in schedule I of the act, and crimes related to them attract the most severe penalties, up to life imprisonment.
Cannabis and related substances are included in schedule II. Crimes involving them attract less severe penalties. In the case of trafficking or possession for the purpose of trafficking, sentences of up to life imprisonment are only imposed in regard to quantities of at least three kilograms. Production of cannabis is punishable by up to seven years in prison.
The least severe penalties of a maximum of 12 months in prison upon summary conviction are reserved for crimes involving substances listed in schedules IV and V. It should be noted, however, that most of the activities forbidden by the Controlled Drugs and Substances Act are legal if the person involved has the necessary licence, permit or exemption.
For example, the marijuana medical access regulations, which took effect on July 30, 2001, provide a complete procedure for people who suffer from certain health problems to apply for a permit to possess or cultivate marijuana for medicinal reasons with the approval of their physician or, in some cases, of a specialist. The number of plants that an authorized person is entitled to cultivate is based on a formula related to the amount of dried marijuana the person needs every day.
Some hon. members might think it is unnecessary to provide for minimum penalties like those in the bill in order to punish serious drug-related offences. However, these crimes are a growing problem in Canadian cities and stricter legislation is absolutely necessary.
We should remember as well that the security of Canadians is one of our government’s highest priorities. Their security is threatened by organized crime groups involved in the production and trafficking of drugs. These activities lead to increased crime, violence and danger to law enforcement officers.
Drug trafficking and production are also the largest sources of illicit money for organized crime groups.
Profits from the sale of drugs, estimated to be in the billions of dollars per year in Canada, are used to finance a host of other criminal activities.
According to the Statistics Canada Juristat bulletin entitled “Crime Statistics in Canada, 2004”, offences related to the cultivation of marijuana more than doubled during the last decade, going from approximately 3,400 in 1994 to 8,000 in 2004. According to a study on marijuana grow operations in British Columbia, approximately 39% of all reported marijuana cultivation cases were located in B.C. Between 1997 and 2000, the total number of these cases increased by over 220%. Even though the number of marijuana grow operations in British Columbia stabilized between 2000 and 2003, the estimated quantity of marijuana produced went from 19,720 kilograms in 1997 to 79,817 kilograms in 2003—a seven-year record—because of the size and proficiency of the operations.
Investigations by British Columbia Hydro revealed that at a certain point there may have been up to 17,000 marijuana grow operations. The increase in illegal marijuana production activities did not occur only in British Columbia, but everywhere in Canada. Even though we have no national data on the production of synthetic drugs, RCMP data indicate a constant increase in production operations. The RCMP carried out seizures in 25 synthetic drug production operations in 2002, in 51 operations in 2003, 60 in 2004, and 53 in 2005. Of these 60 seizures in 2004, 17 involved ecstasy production and 40, methamphetamine production. Of the 53 seizures in 2005, 60% involved methamphetamine production operations and 30% involved ecstasy production operations. The seizures of ecstasy and its components went from 1.5 million tablets in 2001 to more than 70 million tablets in 2006.
Illegal drug use can hurt us all. We are seeing that when it comes to methamphetamine producers and users. Unlike better-known drugs—heroin, cocaine, and marijuana—methamphetamine presents unique challenges. Methamphetamine is a synthetic drug. Its production does not involve crop cultivation. In fact, one needs no special knowledge or training to produce it, and the chemical ingredients are relatively cheap and easy to obtain. As a result, the production of this drug is attractive to both pushers and addicts.
Methamphetamine also poses a threat to enforcement authorities, which have to fight both small, secret labs and huge labs controlled by drug-trafficking organizations.
The small labs produce relatively small amounts of methamphetamine and are generally not affiliated with major drug trafficking organizations. A number of factors have served as catalysts for the spread of small labs, including easy access to recipes on the Internet. Indeed, widespread Internet usage has facilitated the dissemination of technology used to manufacture methamphetamine in small labs. This form of information sharing allows wide dissemination of these techniques to anyone with computer access.
Aside from marijuana, methamphetamine is the only widely used illegal drug that users can make themselves. Given the relative ease with which manufacturers or cooks can acquire recipes and ingredients, and the unsophisticated nature of the production process, it is easy to see why this highly addictive drug is spreading.
Methamphetamine production operations also pose serious public safety and health hazards to those in and around them. These operations can result in serious physical injury from explosions, fires, chemical burns and toxic fumes. They produce environmental hazards, pose cleanup problems and endanger the lives and health of community residents.
The collateral damage caused by methamphetamine includes impacts on families, school staff, students, law enforcers, fire fighters, paramedics, health care practitioners, businesses and property owners. These individuals suffer indirectly from meth use.
First responders may be exposed to production byproducts—the danger of fire or explosion—and may be the target of violence and aggression from addicts.
Communities in general may be exposed to violence, property damage, identity theft, decreased public safety, contamination of public areas from the disposal of cooking byproducts, and an unreliable or decreased workforce that impedes the safety of co-workers.
As you can see, Mr. Speaker, the use and production of illicit drugs can have serious adverse consequences for users, producers, families, law enforcement agencies, first responders and the community.
It is our responsibility as parliamentarians to make the laws in Canada, and we must ensure that those laws provide for appropriate measures to address serious problems. And make no mistake, drug use in Canada is a very serious problem. Some aspects of the situation have grown worse in recent years, and it is our duty to act in the face of this growing threat.
In response to the dangers posed by increased production and the worsening drug problem, the government introduced this bill, which proposes mandatory minimum penalties for those who produce and sell this drug.
The proposed amendments to the Controlled Drugs and Substances Act do more than just impose minimum penalties. The bill contains a provision that would enable certain offenders who ordinarily would be subject to mandatory minimum penalties to take part in a program given by what is called a drug treatment court.
A drug treatment court is a substance abuse intervention model that operates within the criminal justice system. Drug treatment courts provide judicially supervised treatment in lieu of incarcerating individuals who have a substance use problem that is related to their criminal activities, for example, drug related offences such as drug possession, use or non-commercial trafficking and/or property offences committed to support their drug use, such as theft or shoplifting.
Individuals may need to meet other requirements specific to individual courts or court systems to be deemed eligible for admission. Eligible accused persons must choose between the drug treatment court program and traditional criminal justice process, which can result in various dispositions ranging from fines to incarceration.
Typically, formal admission into a drug treatment court program requires the individual to plead guilty to his or her charges. If an individual fails to comply or participate in all aspects of the drug treatment court program, consequences range from an official reprimand or revocation of bail to termination of the program and the handing down of custodial or community supervision sentences.
Although a drug treatment court program is applicable only when eligible offenders choose it and give their consent, drug treatment courts constitute a form of coercive treatment. A well designed and properly implemented drug treatment court model has a number of key facets. The first is early identification of those who meet the program eligibility criteria and early treatment. Second, it includes access to several types of programs that treat the offender's problems with substance abuse, such as alcohol or drugs, and mental health issues.
Third, there is extensive ongoing judicial contact with each participant. Fourth, there must be intensive supervision and drug testing to monitor and ensure abstinence from all intoxicants, coupled with positive reinforcement for compliance and sanctions for non-compliance. Fifth, a partnership is needed between drug treatment courts and community based organizations in order to improve program effectiveness. Sixth, there must be continuing education for those involved in the field, in order to improve the program's effectiveness. Seventh, a non-adversarial approach must be used in the court system to ensure both public safety and the rights of program participants. Eighth and last, comprehensive evaluation will monitor program objectives and measure effectiveness.
Compared to traditional criminal justice approaches, the intent of a drug treatment court is to permit motivated clients to avoid incarceration and other sanctions and to allow them access to treatment services more quickly due to dedicated resources. It is also to encourage clients to remain in treatment until completed, through intensive and frequent monitoring and supervision by the court.
Participating in a drug treatment court program is intensive and demanding. It includes court attendance up to twice a week, random urine testing, and attendance and treatment from daily to weekly as clients progress through the program. Although some participants start treatment in a facility, they all attend outpatient programs.
At some sites there is a primary treatment provider, whereas at other sites various community agencies deliver treatments. The drug treatment court team follows the client's progress closely. There are preliminary meetings set up to detect problems and find possible solutions to difficulties, to client relapse and to non-compliance. Coming before the court enables the client to inform it of his progress, and for it to reinforce compliance and progress made, and to sanction non-compliance or set new conditions or interventions with a view to helping the client break out of the crime-dependence cycle.
The drug treatment court programs show great promise and their results will be monitored. This important bill has been drafted in such a way as to not have any impact on treatment programs.
Canadians are calling for the criminal law system to set proper penalties for the commission of drug-related crimes. This bill responds to that desire and will provide for severe but fair minimum sentences.
